新药实验操作中两员工窒息死亡，调查报告公布！知名上市公司总裁被建议处罚，其年薪超190万元，公司曾因两女员工实验室互殴刷屏

Core Viewpoint - A fatal accident occurred at Kanglong Chemical (Beijing) Co., Ltd., resulting in the death of two employees during a laboratory experiment, raising concerns about safety protocols and management accountability [1][3][4]. Group 1: Accident Details - The incident took place on June 3, 2023, during the operation of a flexible isolator for a project involving an innovative drug for treating muscular dystrophy, currently in the IND approval stage [3]. - The cause of death was identified as suffocation due to a significant drop in oxygen levels caused by nitrogen being introduced into the flexible isolator [3][4]. - The investigation revealed that the employees did not follow safety protocols, specifically failing to use gloves while operating inside the isolator, which directly led to the accident [3][4]. Group 2: Management Accountability - The investigation suggested that the company's management, including the CEO, failed to enforce safety regulations, leading to recommendations for fines against several executives [4][6]. - The CEO, Lou Xiaoqiang, has a reported annual salary of 1.91 million yuan, and the company may face fines ranging from 300,000 to 1 million yuan due to safety violations [4][6]. Group 3: Company Performance - Kanglong Chemical reported a revenue of approximately 6.441 billion yuan for the first half of 2023, a year-on-year increase of 14.93%, while net profit decreased by 37% to about 701 million yuan [8]. - The company experienced a net cash flow from operating activities of 1.408 billion yuan, a 28.06% increase year-on-year, but reported a total net cash flow of -415 million yuan due to reduced financing activities [8]. - Despite recent controversies, including an incident involving employee conflict, the company maintains that such events do not impact its overall operations [8][10]. Group 4: Market Position - Kanglong Chemical, established in 2004, is a leading life sciences research service provider with operations in China, the U.S., and the U.K., employing over 20,000 staff [6]. - The company went public in 2019 and has seen its stock price decline since October 2021, with a current share price of 35.01 yuan, resulting in a market capitalization of 62.2 billion yuan [10].